{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:24:55Z","timestamp":1774538695915,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.contraception.2012.07.001","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T13:15:55Z","timestamp":1344863755000},"page":"193-200","source":"Crossref","is-referenced-by-count":29,"title":["Pharmacokinetic profile of nomegestrol acetate and 17\u03b2-estradiol after multiple and single dosing in healthy women"],"prefix":"10.1016","volume":"87","author":[{"given":"Mireille G.F.","family":"Gerrits","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teun M.","family":"Post","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre A.M.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.07.001_bb0005","author":"United Nations"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2012.07.001_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2012.07.001_bb0015","series-title":"Medical physiology","first-page":"684","article-title":"Fertilization, pregnancy, and fetal development","author":"Terranova","year":"2003"},{"key":"10.1016\/j.contraception.2012.07.001_bb0020","first-page":"CD003989","article-title":"20 microg versus >20 microg estrogen combined oral contraceptives for contraception","author":"Gallo","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.07.001_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(99)00109-2","article-title":"Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations","volume":"60","author":"Rosenberg","year":"1999","journal-title":"Contraception"},{"issue":"Suppl. 4","key":"10.1016\/j.contraception.2012.07.001_bb0030","first-page":"S5","article-title":"Oral contraceptive update: new agents and regimens","volume":"53","author":"Sulak","year":"2004","journal-title":"J Fam Pract"},{"issue":"Suppl. 2","key":"10.1016\/j.contraception.2012.07.001_bb0035","first-page":"9","article-title":"The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 microg and ethinylestradiol 15 microg","volume":"4","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.07.001_bb0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.001_bb0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0149-2918(00)88272-7","article-title":"International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 microg and ethinyl estradiol 20 microg","volume":"21","author":"Boerrigter","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.contraception.2012.07.001_bb0050","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/106002809502907-817","article-title":"Desogestrel, norgestimate, and gestodene: the newer progestins","volume":"29","author":"Kaplan","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.contraception.2012.07.001_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1783\/147118903101197188","article-title":"Newer progestogens","volume":"29","author":"Rowlands","year":"2003","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.07.001_bb0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2012.07.001_bb0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.steroids.2011.02.002","article-title":"Nomegestrol acetate, a novel progestogen for oral contraception","volume":"76","author":"Mueck","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2012.07.001_bb0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2012.07.001_bb0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jsbmb.2003.08.003","article-title":"An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells","volume":"87","author":"Shields-Botella","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2012.07.001_bb0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.contraception.2010.11.017","article-title":"Nomegestrol acetate: steroid receptor transactivation profile in Chinese hamster ovary cells and ovulation inhibition in rat and monkey","volume":"84","author":"van Diepen","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.001_bb0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1783\/147118910793048665","article-title":"50 years of \"The Pill\": celebrating a golden anniversary","volume":"36","author":"Szarewski","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.07.001_bb0090","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.07.001_bb0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-7824(02)00436-5","article-title":"Effect of four different oral contraceptives on various sex hormones and serum-binding globulins","volume":"67","author":"Wiegratz","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.001_bb0100","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-7824(80)90010-4","article-title":"A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens","volume":"21","author":"World Health Organization Task Force on Oral Contraception","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.001_bb0105","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-0528.1979.tb11276.x","article-title":"Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol","volume":"86","author":"Astedt","year":"1979","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.07.001_bb0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.1.6056.269","article-title":"The natural oestrogenic hormone oestradiol as a new component of combined oral contraceptives","volume":"1","author":"Astedt","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2012.07.001_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-5122(94)00856-3","article-title":"Oral contraceptive containing natural estradiol for premenopausal women","volume":"21","author":"Hirvonen","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2012.07.001_bb0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-5122(88)90023-0","article-title":"New natural oestradiol\/cyproterone acetate oral contraceptive for pre-menopausal women","volume":"10","author":"Hirvonen","year":"1988","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2012.07.001_bb0125","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0940-2993(98)80034-1","article-title":"Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives","volume":"50","author":"Hoffmann","year":"1998","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.contraception.2012.07.001_bb0130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(79)91525-3","article-title":"Natural oestrogens for oral contraception","volume":"2","author":"Serup","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.07.001_bb0135","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0015-0282(16)56210-4","article-title":"Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol","volume":"60","author":"Wenzl","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.07.001_bb0140","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/13625187.2010.504313","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol","volume":"15","author":"Duijkers","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.07.001_bb0145","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/13625187.2011.614029","article-title":"Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen","volume":"16","author":"Mansour","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.07.001_bb0150","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/AOG.0b013e318250c3a0","article-title":"Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17beta-estradiol: a randomized controlled trial","volume":"119","author":"Westhoff","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.07.001_bb0155","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0960-0760(93)90105-6","article-title":"Enzyme immunoassay for nomegestrol acetate in human plasma","volume":"46","author":"Ezan","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2012.07.001_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13625180902850039","article-title":"Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest","volume":"14","author":"Zeun","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.07.001_bb0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"Suppl. 3","key":"10.1016\/j.contraception.2012.07.001_bb0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13697130500330382","article-title":"Pharmacology of different progestogens: the special case of drospirenone","volume":"8","author":"Sitruk-Ware","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2012.07.001_bb0175","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1471-0528.1987.tb02322.x","article-title":"Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary-ovarian function in women","volume":"94","author":"Bazin","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.07.001_bb0180","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1507\/endocrj.52.407","article-title":"Relationship between sex hormone-binding globulin and pregnancy outcome in women undergoing controlled ovarian hyperstimulation for assisted reproduction","volume":"52","author":"Lin","year":"2005","journal-title":"Endocr J"},{"key":"10.1016\/j.contraception.2012.07.001_bb0185","series-title":"Medical physiology","first-page":"667","article-title":"The female reproductive system","author":"Terranova","year":"2003"},{"key":"10.1016\/j.contraception.2012.07.001_bb0190","first-page":"758","article-title":"Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol","volume":"77","author":"Scott","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.07.001_bb0195","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.1989.tb02232.x","article-title":"Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotrophin release, bone turnover and climacteric symptoms in postmenopausal women","volume":"30","author":"Selby","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.contraception.2012.07.001_bb0200","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0029-7844(96)00513-3","article-title":"Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol","volume":"89","author":"Price","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.07.001_bb0205","first-page":"766","article-title":"Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol","volume":"46","author":"Setnikar","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.contraception.2012.07.001_bb0210","first-page":"966","article-title":"Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17 beta-estradiol","volume":"43","author":"Kuhnz","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.contraception.2012.07.001_bb0215","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/13625187.2011.614363","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17beta-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function","volume":"16","author":"Agren","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.07.001_bb0220","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2165\/11532130-000000000-00000","article-title":"Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy","volume":"70","author":"Lello","year":"2010","journal-title":"Drugs"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412006671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412006671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T09:00:46Z","timestamp":1542790846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412006671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0010782412006671"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.07.001","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}